Pathophysiology and Management of Drug Allergy-Induced Rashes

Management Table

Important Note: Always perform a thorough physical examination to rule out anaphylaxis, which includes checking for MP rash, wheezing, hypotension, and other signs of severe allergic reactions. Immediate intervention is required if any signs of anaphylaxis are detected. Introduction In addition to the complications arising from the transfusion of Fresh Frozen Plasma (FFP), patients can also develop allergic reactions to medications. These reactions often manifest as skin rashes, which can range from mild to severe. This article explores the types of drug-induced rashes, and their characteristics, and outlines the appropriate management strategies for patients, including those who can take oral medications and those who are NPO (nil per os, nothing by mouth).

Pathophysiology of Drug Allergy-Induced Rashes

Drug allergies occur when the immune system reacts to a medication as if it were a harmful substance. This reaction can trigger a variety of symptoms, including skin rashes. The two most common types of drug-induced rashes are urticaria and maculopapular rashes.

• Urticaria (Hives)
  • Characteristics: Urticaria is characterized by raised, itchy welts that can vary in size and shape. These welts, or hives, often appear suddenly and can migrate around the body. The welts are typically red or skin-colored and can appear anywhere on the body.
  • Mechanism: Urticaria results from the release of histamines and other inflammatory mediators from mast cells in response to an allergen.
• Maculopapular Rash
  • Characteristics: A maculopapular rash consists of both macules (flat, discolored spots) and papules (small, raised bumps). This type of rash often presents as red spots that may merge to form larger patches. It typically starts on the trunk and spreads to the limbs.
  • Mechanism: This rash is often due to a delayed hypersensitivity reaction involving T-cells and other immune components.

Management and Dosage

For managing drug allergy-induced rashes, the approach depends on whether the patient can take oral medications or is NPO.

• If the Patient Can Eat
  • Antihistamines
    • Cetirizine (Zyrtec)
      • Indication: Used to relieve symptoms of urticaria and maculopapular rash.
      • Dosage: 10 mg orally once daily.
    • Loratadine (Claritin)
      • Indication: Used to relieve symptoms of urticaria and maculopapular rash.
      • Dosage: 10 mg orally once daily.
  • Corticosteroids
    • Prednisone
      • Indication: Used for severe allergic reactions to reduce inflammation.
      • Dosage: 20-40 mg orally once daily for a short course (typically 5-7 days).
  • Hydration and Symptomatic Care
    • Encourage oral hydration and apply cool compresses to the affected areas to alleviate itching.
• If the Patient is NPO
  • Antihistamines
    • Chlorpheniramine (CPM)
      • Indication: Used to relieve symptoms of urticaria and maculopapular rash.
      • Dosage: 10-20 mg intravenously every 6-12 hours as needed.
  • Corticosteroids
    • Hydrocortisone
      • Indication: Used for severe allergic reactions to reduce inflammation.
      • Dosage: 100 mg IV bolus in emergency situations.
    • Methylprednisolone (Solu-Medrol)
      • Indication: Used for severe allergic reactions.
      • Dosage: 40-125 mg IV, based on the severity of symptoms.
  • Hydration and Symptomatic Care
    • Provide IV fluids to maintain hydration and use cool compresses to alleviate itching.

Assessment for Anaphylaxis

Regardless of the patient's ability to take oral medications, it is crucial to assess for signs of anaphylaxis, which is a severe, life-threatening allergic reaction. Signs of anaphylaxis include:

• Skin: Widespread hives (urticaria), angioedema (swelling, often around the eyes and lips), and maculopapular rash.
• Respiratory: Wheezing, stridor, difficulty breathing, and bronchospasm.
• Cardiovascular: Hypotension, tachycardia, and shock.
• Gastrointestinal: Nausea, vomiting, diarrhea, and abdominal pain.

Management of Anaphylaxis

• Epinephrine
  • Indication: First-line treatment for anaphylaxis.
  • Dosage: 0.3-0.5 mg intramuscularly (IM) in the mid-outer thigh. Repeat every 5-15 minutes if symptoms persist.
• Supportive Care
  • Oxygen: Administer 100% oxygen via non-rebreather mask.
  • IV Fluids: Rapid infusion of isotonic crystalloids (e.g., normal saline) to maintain blood pressure.
  • Antihistamines and Corticosteroids: Continue administration as described above to manage ongoing allergic symptoms.

Conclusion

Drug allergies can present with a variety of skin rashes, most commonly urticaria and maculopapular rashes. Proper management involves the use of antihistamines and corticosteroids, tailored to whether the patient can take oral medications or is NPO. It is essential to assess for signs of anaphylaxis in all cases of drug allergies to ensure timely and appropriate intervention. Understanding the pathophysiology and treatment options for drug-induced rashes ensures effective patient care and improves outcomes. Always consult with a healthcare provider for tailored medical advice and treatment plans.